Literature DB >> 3612211

High-dose intravenous gamma-globulin therapy for myasthenia gravis.

I B Ibars, J Ponseti, T Español, J Matias-Guiu, A Codina-Puiggros.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3612211     DOI： 10.1007/bf00314298

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  High-dose intravenous gammaglobulin for myasthenia gravis.

Authors:  G Ippoliti; V Cosi; G Piccolo; M Lombardi; R Mantegaz
Journal:  Lancet       Date:  1984-10-06       Impact factor: 79.321

2.  High-dose intravenous gammaglobulin for myasthenia gravis.

Authors:  A Fateh-Moghadam; M Wick; U Besinger; R G Geursen
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

3.  High-dose intravenous gammaglobulin for myasthenia gravis.

Authors:  P Gajdos; H Outin; D Elkharrat; D Brunel; P de Rohan-Chabot; J C Raphael; M Goulon; C Goulon-Goeau; E Morel
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

4.  Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.

Authors:  S Mossman; A Vincent; J Newsom-Davis
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.